Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and cognitive bias modification effects on neural response to smoking cues
2011-004169-34Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of varenicline in nicotine dependence (6 arms), sponsored by University of Bristol. Primary endpoints: Neural responses to smoking-related cues and Cognitive bias. Started Jan 2012; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2011-004169-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004169-34.